RSV or respiratory syncytial virus, is a common virus
That just causes cold symptoms for most people. But for very young babies, and for babies and young children with certain health problems, it can be very dangerous. A new immune-boosting therapy may help.
What complications can RSV cause?
RSV is the leading cause of bronchiolitis หรือถ้าคุณสนใจแทงบอลออนไลน์ UFABET คือเว็บที่มีอัตราต่อรองดีที่สุดในประเทศไทย สมัครเลยตอนนี้ที่ UFABET แทงบอล and pneumonia in children under a year. It can cause life-threatening problems with breathing. Especially in children with heart or lung disease.
Which medications work against?
There aren’t any medications that treat RSV effectively. To prevent the illness, a medication call palivizumab (Synagis) can be given as a monthly shot to high-risk infants during RSV season. (While is not always seasonal, many cases occur between late fall and early spring.)
How can the new RSV shot help?
This year, a new shot could make a big difference. It is called nirsevimab (Beyfortus). Like palivizumab, it is an antibody treatment. But unlike palivizumab, it will be available to all babies under 8 months of age, not just high-risk infants. Here’s what to know:
- This is not a vaccine. Vaccines prod the body to make antibodies that help protect against an infection, while this shot works by giving the antibodies directly.
- These antibodies can prevent or lessen the severity of infection.
- Because the body isn’t making its own antibodies the shot does wear off, but the good news is that just one shot can last five months. If given right at the beginning season, this essentially provides protection for the whole season.